XML 25 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME/(LOSS) - USD ($)
$ in Thousands
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Apr. 30, 2020
Income Statement [Abstract]      
Net sales (including $2.4 million of related party sales for the four months of our fiscal year 2021 prior to the Separation, and $15.1 million of related party sales for our fiscal year 2020) $ 247,526 $ 276,687 $ 167,379
Cost of sales 133,287 149,859 96,363
Gross profit 114,239 126,828 71,016
Operating expenses:      
Research and development 5,501 5,378 4,995
Selling, marketing, and distribution 56,168 56,773 38,596
General and administrative 41,244 41,182 41,292
Goodwill impairment 67,849   98,929
Total operating expenses 170,762 103,333 183,812
Operating (loss)/income (56,523) 23,495 (112,796)
Other income/(expense), net:      
Other income/(loss), net 1,311 497 (21)
Interest (expense)/income, net (324) 300 4,963
Total other income, net 987 797 4,942
(Loss)/income from operations before income taxes (55,536) 24,292 (107,854)
Income tax expense/(benefit) 9,344 5,887 (11,653)
Net (loss)/income/comprehensive (loss)/income $ (64,880) $ 18,405 $ (96,201)
Net (loss)/income per share:      
Basic $ (4.66) $ 1.31 $ (6.88)
Diluted $ (4.66) $ 1.29 $ (6.88)
Weighted average number of common shares outstanding:      
Basic 13,930,000 13,997,000 13,975,000
Diluted 13,930,000 14,225,000 13,975,000